BioXcel Therapeutics Newsroom

H.C. Wainwright Maintains BioXcel Therapeutics(BTAI.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsOct 22 18:32 ET

BioXcel Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesOct 21 06:30 ET

BioXcel Therapeutics Analyst Ratings

BenzingaOct 21 06:21 ET

Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI) and Arcutis Biotherapeutics (ARQT)

TipRanksSep 25 07:53 ET

Mizuho Securities Maintains BioXcel Therapeutics(BTAI.US) With Hold Rating, Announces Target Price $1

Moomoo NewsSep 9 18:31 ET

Bioxcel Therapeutics Earns Buy Rating on Promising Clinical Trials and Market Potential

TipRanksSep 6 06:34 ET

BioXcel Therapeutics Price Target Maintained With a $7.00/Share by Canaccord Genuity

Dow JonesAug 30 11:52 ET

BioXcel Therapeutics Analyst Ratings

BenzingaAug 30 11:42 ET

Bioxcel Therapeutics (BTAI) Receives a Hold From Mizuho Securities

TipRanksAug 12 02:29 ET

BioXcel Therapeutics Analyst Ratings

BenzingaAug 8 17:06 ET

Buy Rating Maintained for Bioxcel Therapeutics Amid Positive Performance and Growth Prospects

TipRanksAug 7 09:19 ET

Canaccord Genuity Maintains Buy on BioXcel Therapeutics, Maintains $7 Price Target

BenzingaJun 27 09:32 ET

BioXcel Therapeutics Analyst Ratings

BenzingaJun 27 09:32 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX), Bioxcel Therapeutics (BTAI) and Prothena (PRTA)

TipRanksMay 29 00:39 ET

Hold Rating on Bioxcel Therapeutics Amid Growth Potential and Financial Uncertainties

TipRanksMay 14 05:15 ET

BioXcel Therapeutics Analyst Ratings

BenzingaMay 10 07:58 ET

HC Wainwright & Co. Reiterates Buy on BioXcel Therapeutics, Maintains $10 Price Target

BenzingaMay 10 07:58 ET

Bullish Outlook: Bioxcel Therapeutics' Revenue Surge and Promising Clinical Trials Fuel Buy Rating

TipRanksMay 10 07:02 ET

Hold Rating on Bioxcel Therapeutics Amid Strategic and Clinical Trial Uncertainties

TipRanksApr 26 02:21 ET

BioXcel Therapeutics Analyst Ratings

BenzingaApr 23 06:32 ET